TCL Archive Rogers Reaffirms Congress’ Interest In Cancer Program; Act Renewal To “Broaden, Sustain It” April 14, 1978
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive NIH establishes new clinical science awards to eventually replace General Clinical Research Centers. October 21, 2005
